Plavix’s New Generic Status Could Be Boon for Patients

<p>TUESDAY, May 15 (HealthDay News) — The blockbuster drug Plavix
(<span>clopidogrel</span>), used to forestall clotting in some <span>heart patients</span>, will go
off obvious in a United States on Thursday, creation it extremely more
affordable. </p>
<p>Adherence rates will urge as a result, and fewer patients will
suffer from preventable cardiovascular problems, pronounced Dr. <span>Gregg Fonarow</span>, a
professor of medicine and executive of a Ahmanson-UCLA Cardiomyopathy
Center in Los Angeles.</p>
<p>“This remedy has helped millions of patients equivocate deadly and
non-fatal cardiovascular events,” pronounced Fonarow, who also is a spokesman
for a <span>American Heart Association</span>. But a high cost has “contributed to
patients not stuffing initial prescriptions for a drug and premature
discontinuation of clopidogrel,” he said.</p>
<p>Patients who stop holding a drug betimes might aft...